(Total Views: 619)
Posted On: 09/03/2020 6:43:08 PM
Post# of 155255
DaveV-1 properly pointed out last nIght that I credited CYDY with possibly eliminating the need for biopsies in Metastatic cancers.
He was correct that Cytodyn nor Leronlimab does that. However, dfwl28 hits what I wanted to say squarely on the head. If we can predict CCR5/CCL5 axis in humans, we can possibly foresee what a biopsy would produce. Predicting metastasis.
If we can figure out which ones of us over-express CCR5, then we can possibly know which ones of us metastasize at a higher rate (leading to complications and death) And which ones don’t.
Huge savings across the globe that can be repurposed for the Good of the Order.
He was correct that Cytodyn nor Leronlimab does that. However, dfwl28 hits what I wanted to say squarely on the head. If we can predict CCR5/CCL5 axis in humans, we can possibly foresee what a biopsy would produce. Predicting metastasis.
If we can figure out which ones of us over-express CCR5, then we can possibly know which ones of us metastasize at a higher rate (leading to complications and death) And which ones don’t.
Huge savings across the globe that can be repurposed for the Good of the Order.
(0)
(0)
